The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan
Open Access
- 11 May 2016
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 13 (5) , 482
Abstract
Menopausal hormone replacement therapy (HRT) increases the risk of breast cancer in Western countries; however, there are fewer reports from the Asian population, which has a lower incidence of breast cancer. A population-based retrospective cohort study was conducted by analyzing longitudinal National Health Insurance claim data of a 200,000-person national representative cohort. A total of 22,929 women aged ≥45 years in 1997 without previous diagnosis of breast cancer were enrolled and stratified into two birth cohorts born before or after 1933. HRT prescriptions were traced in outpatient data files and incident breast cancer cases were identified from 1997 to 2004. The Cox proportional hazards model was used to analyze breast cancer hazard ratio (HR). HRT users were censored after they discontinued HRT. The results showed that women born during 1933–1952 had a twofold increased risk of breast cancer (HR = 2.10, 95% CI = 1.47–3.00) compared with women born before 1933, when adjusted for HRT use. When adjusted for the birth-cohort difference, HRT users had significantly increased breast cancer HR versus non-users after four years of use (adjusted HR = 1.48, 95% CI = 1.03–2.13); the HR further increased to 1.95 (95% CI = 1.34–2.84) after eight years of use. In conclusion, a longer duration of current HRT use was associated with a higher risk of breast cancer independent of the birth-cohort difference.Keywords
This publication has 26 references indexed in Scilit:
- Invasive breast cancer incidence trends by detailed race/ethnicity and ageInternational Journal of Cancer, 2011
- Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian womenCancer Causes & Control, 2010
- Hidden Breast Cancer Disparities in Asian Women: Disaggregating Incidence Rates by Ethnicity and Migrant StatusAmerican Journal of Public Health, 2010
- Changes of the prescription of hormone therapy in menopausal women: An observational study in TaiwanBMC Public Health, 2007
- Body size, hormone therapy and risk of breast cancer in Asian–American womenInternational Journal of Cancer, 2006
- Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: Supporting the Women's Health Initiative studyJournal of Obstetrics and Gynaecology Research, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997